Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Daniela Gilardi, Roberto Gabbiadini, Mariangela Allocca, Carmen Correale, Gionata Fiorino, Federica Furfaro, Alessandra Zilli, Laurent Peyrin-Biroulet & Silvio Danese. (2020) PK, PD, and interactions: the new scenario with JAK inhibitors and S1P receptor modulators, two classes of small molecule drugs, in IBD. Expert Review of Gastroenterology & Hepatology 14:9, pages 797-806.
Read now
Read now
Hassaan Bashir. (2019) Emerging therapies in Huntington’s disease. Expert Review of Neurotherapeutics 19:10, pages 983-995.
Read now
Read now
Brandon Wilbanks, LJ Maher$suffix/text()$suffix/text() & Moses Rodriguez. (2019) Glial cells as therapeutic targets in progressive multiple sclerosis. Expert Review of Neurotherapeutics 19:6, pages 481-494.
Read now
Read now
Ignacio Catalan-Serra & Øystein Brenna. (2018) Immunotherapy in inflammatory bowel disease: Novel and emerging treatments. Human Vaccines & Immunotherapeutics 14:11, pages 2597-2611.
Read now
Read now
Ram Narendra Narayan, Thomas Forsthuber & Olaf Stüve. (2018) Emerging drugs for primary progressive multiple sclerosis. Expert Opinion on Emerging Drugs 23:2, pages 97-110.
Read now
Read now
Judith Austermann, Stefanie Zenker & Johannes Roth. (2017) S100-alarmins: potential therapeutic targets for arthritis. Expert Opinion on Therapeutic Targets 21:7, pages 738-750.
Read now
Read now
Articles from other publishers (29)
Dnyandev G. Gadhave, Vrashabh V. Sugandhi & Chandrakant R. Kokare. (2024) Potential biomaterials and experimental animal models for inventing new drug delivery approaches in the neurodegenerative disorder: Multiple sclerosis. Brain Research 1822, pages 148674.
Crossref
Crossref
Zhiyuan Ning, Ying Liu, Daji Guo, Wei-Jye Lin & Yamei Tang. (2023) Natural killer cells in the central nervous system. Cell Communication and Signaling 21:1.
Crossref
Crossref
Magdalena Chylińska, Jakub Komendziński, Adam Wyszomirski & Bartosz Karaszewski. (2023) Brain Atrophy as an Outcome of Disease-Modifying Therapy for Remitting-Relapsing Multiple Sclerosis. Multiple Sclerosis International 2023, pages 1-11.
Crossref
Crossref
Felix Kohle, Marinos C. Dalakas & Helmar C. Lehmann. (2023) Repurposing MS immunotherapies for CIDP and other autoimmune neuropathies: unfulfilled promise or efficient strategy?. Therapeutic Advances in Neurological Disorders 16, pages 175628642211371.
Crossref
Crossref
Rongzeng Liu, Shushu Du, Lili Zhao, Sahil Jain, Kritika Sahay, Albert Rizvanov, Vera Lezhnyova, Timur Khaibullin, Ekaterina Martynova, Svetlana Khaiboullina & Manoj Baranwal. (2022) Autoreactive lymphocytes in multiple sclerosis: Pathogenesis and treatment target. Frontiers in Immunology 13.
Crossref
Crossref
Lindsey H. Forbes & Veronique E. Miron. (2021) Monocytes in central nervous system remyelination. Glia 70:5, pages 797-807.
Crossref
Crossref
Rodica Balasa, Laura Barcutean, Oana Mosora & Doina Manu. (2021) Reviewing the Significance of Blood–Brain Barrier Disruption in Multiple Sclerosis Pathology and Treatment. International Journal of Molecular Sciences 22:16, pages 8370.
Crossref
Crossref
Rina Aharoni, Raya Eilam & Ruth Arnon. (2021) Astrocytes in Multiple Sclerosis—Essential Constituents with Diverse Multifaceted Functions. International Journal of Molecular Sciences 22:11, pages 5904.
Crossref
Crossref
Donald J. AbrahamWilliam J. Pitts & Alaric J. Dyckman. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
43
.
Sinah Engel, Valérie JolivelStefan H.-P. KrausMorad ZayoudKarolina RosenfeldHayrettin TumaniRoberto FurlanFlorian C. KurschusAri Waisman & Felix Luessi. (2021) Laquinimod dampens IL-1β signaling and Th17-polarizing capacity of monocytes in patients with MS. Neurology Neuroimmunology & Neuroinflammation 8:1.
Crossref
Crossref
Abdullah Al Mamun, Ilma Monalisa, Khadija Tul Kubra, Afroza Akter, Jaheda Akter, Tamanna Sarker, Fahad Munir, Yanqing Wu, Chang Jia, Masuma Afrin Taniya & Jian Xiao. (2021) Advances in immunotherapy for the treatment of spinal cord injury. Immunobiology 226:1, pages 152033.
Crossref
Crossref
Hengri Cong, Ming Zhang, Haoxiao Chang, Li Du, Xinghu Zhang & Linlin Yin. (2020) Icariin ameliorates the progression of experimental autoimmune encephalomyelitis by down-regulating the major inflammatory signal pathways in a mouse relapse-remission model of multiple sclerosis. European Journal of Pharmacology 885, pages 173523.
Crossref
Crossref
Sudip Mukherjee, Vijay Sagar Madamsetty, Dwaipayan Bhattacharya, Sayan Roy Chowdhury, Manash Kumar Paul & Anubhab Mukherjee. (2020) Recent Advancements of Nanomedicine in Neurodegenerative Disorders Theranostics. Advanced Functional Materials 30:35.
Crossref
Crossref
Peng Yin, Qiong Liu, Yongcheng Pan, Weili Yang, Su Yang, Wenjie Wei, Xingxing Chen, Yan Hong, Dazhang Bai, Xiao‐Jiang Li & Shihua Li. (2020)
Phosphorylation of myelin regulatory factor by
PRKG
2 mediates demyelination in Huntington's disease
. EMBO reports 21:6.
Crossref
Crossref
Valentina Pegoretti, Kathryn A. Swanson, John R. Bethea, Lesley Probert, Ulrich L. M. Eisel & Roman Fischer. (2020) Inflammation and Oxidative Stress in Multiple Sclerosis: Consequences for Therapy Development. Oxidative Medicine and Cellular Longevity 2020, pages 1-19.
Crossref
Crossref
Faeze Rouhi, Zinat Mohammadpour, Sakineh Kazemi Noureini, Hedayat Abbastabar, Mohammad Hossein Harirchian & Sama Bitarafan. (2020) The effects and side effects of laquinimod for the treatment of multiple sclerosis patients: a systematic review and meta-analysis of clinical trials. European Journal of Clinical Pharmacology 76:5, pages 611-622.
Crossref
Crossref
Ali Afrasiabi, Grant P. Parnell, Sanjay Swaminathan, Graeme J. Stewart & David R. Booth. (2020) The interaction of Multiple Sclerosis risk loci with Epstein-Barr virus phenotypes implicates the virus in pathogenesis. Scientific Reports 10:1.
Crossref
Crossref
Muhibullah S. Tora, Pavlos Texakalidis, Alex Greven, Razan Faraj, Julian L. Gendreau, Zhijia Liang, Thais Federici & Nicholas M. Boulis. 2020. Handbook of Innovations in Central Nervous System Regenerative Medicine. Handbook of Innovations in Central Nervous System Regenerative Medicine
435
486
.
Tiago A. Mestre. (2019) Recent advances in the therapeutic development for Huntington disease. Parkinsonism & Related Disorders 59, pages 125-130.
Crossref
Crossref
Elizabeth A Mills, Joel A Begay, Caitlyn Fisher & Yang Mao-Draayer. (2018) Impact of trial design and patient heterogeneity on the identification of clinically effective therapies for progressive MS. Multiple Sclerosis Journal 24:14, pages 1795-1807.
Crossref
Crossref
Srinivasa Reddy Bonam, Fengjuan Wang & Sylviane Muller. (2018) Autophagy: A new concept in autoimmunity regulation and a novel therapeutic option. Journal of Autoimmunity 94, pages 16-32.
Crossref
Crossref
Xuemei Qiu, Qingqing Guo, Xue Liu, Hui Luo, Danping Fan, Yongqi Deng, Hua Cui, Cheng Lu, Ge Zhang, Xiaojuan He & Aiping Lu. (2018) Pien Tze Huang Alleviates Relapsing-Remitting Experimental Autoimmune Encephalomyelitis Mice by Regulating Th1 and Th17 Cells. Frontiers in Pharmacology 9.
Crossref
Crossref
Selma Mahiout, Sara Giani Tagliabue, Atefeh Nasri, Iyekhoetin Matthew Omoruyi, Lars Pettersson, Laura Bonati & Raimo Pohjanvirta. (2018) In vitro toxicity and in silico docking analysis of two novel selective AH-receptor modulators. Toxicology in Vitro 52, pages 178-188.
Crossref
Crossref
Sure Siva Prasad, Narra Rajashekar Reddy & Sundarababu Baskaran. (2018) One-Pot Synthesis of Structurally Diverse Iminosugar-Based Hybrid Molecules. The Journal of Organic Chemistry 83:17, pages 9604-9618.
Crossref
Crossref
Jun Shu, Xiaojuan He, Hong Li, Xue Liu, Xuemei Qiu, Tongliang Zhou, Ping Wang & Xiaojie Huang. (2018) The Beneficial Effect of Human Amnion Mesenchymal Cells in Inhibition of Inflammation and Induction of Neuronal Repair in EAE Mice. Journal of Immunology Research 2018, pages 1-10.
Crossref
Crossref
Raj Putatunda, John R. Bethea & Wen-Hui Hu. (2018) Potential immunotherapies for traumatic brain and spinal cord injury. Chinese Journal of Traumatology 21:3, pages 125-136.
Crossref
Crossref
Cortnee Roman & Kara Menning. (2017) Treatment and disease management of multiple sclerosis patients. Journal of the American Association of Nurse Practitioners 29:10, pages 629-638.
Crossref
Crossref
Ahmed Abdelhak, Martin S. Weber & Hayrettin Tumani. (2017) Primary Progressive Multiple Sclerosis: Putting Together the Puzzle. Frontiers in Neurology 8.
Crossref
Crossref
Sanam Dolati, Zohreh Babaloo, Farhad Jadidi-Niaragh, Hormoz Ayromlou, Sanam Sadreddini & Mehdi Yousefi. (2017) Multiple sclerosis: Therapeutic applications of advancing drug delivery systems. Biomedicine & Pharmacotherapy 86, pages 343-353.
Crossref
Crossref